Amorepacific to support 'New Beauty Research Initiative'

By

Jennifer Braun

Published
Dec 18, 2022

South Korean beauty and cosmetics conglomerate Amorepacific Corporation has partnered with the Johns Hopkins Department of Dermatology to support a new research program, dubbed the 'New Beauty Research Initiative' (NBRI).   

Under a gift agreement, Amorepacific will support the upcoming mid-to-long-term research program, in fostering innovative research and advancements for the health and beauty of consumers.

The program is in line with Johns Hopkins' commitment to support science innovation, which covers a wide range of fields including fundamental studies and clinical research, to study new targets and mechanisms while also carrying out clinical bioactivity tests on original materials developed by Amorepacific.

"This collaboration between our two world-class organizations will contribute to a significant improvement in skin science," said Dr. YoungHo Park, CTO, Amorepacific Research and Innovation Center, who attended a signing ceremony on December 5, 2022. "We could not be more excited about advancing technologies to US customers.”

Amorepacific first collaborated with Johns Hopkins Department of Dermatology in 2020, to conduct a clinical study on the "Evaluation of Epigenetic Changes Related to Skin Aging." 

The new initiative joins the company’s many global research hubs that are dedicated to sustainable research and development.